Yea Christopher
Insider CIK 1691102 · KALV Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 31,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 60,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 27,900 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 20,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 18,920 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 80,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 25,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 41,250 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 52,600 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 53,500 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer | 2026-06-11 | 2026-06-11 | 229,918 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-27 | 2026-05-29 | 33,800 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-27 | 2026-05-29 | 33,800 | $7.07 | $239.0K | 263,718 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-27 | 2026-05-29 | 33,800 | $26.78 | $905.2K | 229,918 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-26 | 2026-05-27 | 1,966 | $26.78 | $52.6K | 229,918 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-22 | 2026-05-27 | 3,125 | — | $0 | 25,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-22 | 2026-05-26 | 2,358 | $26.78 | $63.1K | 228,759 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-22 | 2026-05-27 | 3,125 | — | $0 | 231,884 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-21 | 2026-05-26 | 3,750 | — | $0 | 41,250 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-21 | 2026-05-26 | 3,750 | — | $0 | 231,117 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-18 | 2026-05-19 | 1,108 | $26.76 | $29.7K | 227,367 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-17 | 2026-05-19 | 1,774 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-17 | 2026-05-19 | 1,774 | — | $0 | 228,475 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-02-23 | 2026-02-24 | 4,347 | $15.57 | $67.7K | 226,701 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-22 | 2026-02-24 | 3,125 | — | $0 | 28,125 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-22 | 2026-02-24 | 3,125 | — | $0 | 231,048 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-21 | 2026-02-24 | 3,750 | — | $0 | 45,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-21 | 2026-02-24 | 3,750 | — | $0 | 227,923 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-02-18 | 2026-02-19 | 1,109 | $15.00 | $16.6K | 224,173 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-17 | 2026-02-19 | 1,774 | — | $0 | 1,774 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-17 | 2026-02-19 | 1,774 | — | $0 | 225,282 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-11-24 | 2025-11-26 | 4,331 | $13.45 | $58.3K | 223,508 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-22 | 2025-11-26 | 3,125 | — | $0 | 31,250 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-22 | 2025-11-26 | 3,125 | — | $0 | 227,839 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-21 | 2025-11-26 | 3,750 | — | $0 | 48,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-21 | 2025-11-26 | 3,750 | — | $0 | 224,714 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-20 | 2025-11-21 | 87,390 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-20 | 2025-11-21 | 87,390 | — | $0 | 220,964 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-11-18 | 2025-11-19 | 2,683 | $14.48 | $38.8K | 133,574 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-17 | 2025-11-19 | 2,431 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-17 | 2025-11-19 | 1,774 | — | $0 | 3,548 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-17 | 2025-11-19 | 4,205 | — | $0 | 136,257 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-08-25 | 2025-08-26 | 1,954 | $13.42 | $26.2K | 132,052 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-22 | 2025-08-26 | 3,125 | — | $0 | 34,375 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-08-22 | 2025-08-25 | 2,362 | $13.22 | $31.2K | 130,881 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-08-22 | 2025-08-26 | 3,125 | — | $0 | 134,006 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-21 | 2025-08-25 | 3,750 | — | $0 | 52,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-08-21 | 2025-08-25 | 3,750 | — | $0 | 133,243 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-08-18 | 2025-08-19 | 2,649 | $13.19 | $34.9K | 129,493 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-17 | 2025-08-19 | 1,773 | — | $0 | 5,322 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-17 | 2025-08-19 | 2,430 | — | $0 | 2,431 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-08-17 | 2025-08-19 | 4,203 | — | $0 | 132,142 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-07-09 | 2025-07-10 | 30,250 | $15.69 | $474.6K | 127,939 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2025-07-08 | 2025-07-10 | 60,000 | — | $0 | 158,189 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-05-23 | 2025-05-27 | 1,926 | $11.31 | $21.8K | 98,189 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-22 | 2025-05-27 | 3,125 | — | $0 | 37,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-05-22 | 2025-05-23 | 2,317 | $11.88 | $27.5K | 96,990 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-05-22 | 2025-05-27 | 3,125 | — | $0 | 100,115 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-21 | 2025-05-23 | 3,750 | — | $0 | 56,250 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-05-21 | 2025-05-23 | 3,750 | — | $0 | 99,307 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-05-19 | 2025-05-20 | 2,600 | $11.84 | $30.8K | 95,557 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-17 | 2025-05-20 | 1,774 | — | $0 | 7,095 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-17 | 2025-05-20 | 2,431 | — | $0 | 4,861 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-05-17 | 2025-05-20 | 4,205 | — | $0 | 98,157 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-02-24 | 2025-02-25 | 1,918 | $10.02 | $19.2K | 93,952 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-02-22 | 2025-02-25 | 3,125 | — | $0 | 40,625 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-02-22 | 2025-02-25 | 3,125 | — | $0 | 95,870 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2025-02-21 | 2025-02-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-02-18 | 2025-02-19 | 2,601 | $9.82 | $25.5K | 92,745 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-02-17 | 2025-02-19 | 2,430 | — | $0 | 7,292 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-02-17 | 2025-02-19 | 1,774 | — | $0 | 8,869 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-02-17 | 2025-02-19 | 4,204 | — | $0 | 95,346 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-11-26 | 2024-11-27 | 1,963 | $9.87 | $19.4K | 91,142 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-22 | 2024-11-27 | 3,125 | — | $0 | 43,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-11-22 | 2024-11-27 | 3,125 | — | $0 | 93,105 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-11-18 | 2024-11-19 | 7,192 | $9.26 | $66.6K | 89,980 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-17 | 2024-11-19 | 1,774 | — | $0 | 10,643 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-17 | 2024-11-19 | 7,291 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-17 | 2024-11-19 | 2,431 | — | $0 | 9,722 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-11-17 | 2024-11-19 | 11,496 | — | $0 | 97,172 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-08-23 | 2024-08-26 | 1,916 | $12.40 | $23.8K | 85,676 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-22 | 2024-08-26 | 3,125 | — | $0 | 46,875 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-08-22 | 2024-08-26 | 3,125 | — | $0 | 87,592 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-08-19 | 2024-08-21 | 7,102 | $12.01 | $85.3K | 84,467 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-17 | 2024-08-21 | 7,292 | — | $0 | 7,291 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-17 | 2024-08-21 | 1,773 | — | $0 | 12,417 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-17 | 2024-08-21 | 2,430 | — | $0 | 12,153 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-08-17 | 2024-08-21 | 11,495 | — | $0 | 91,569 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-05-22 | 2024-05-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-05-20 | 2024-05-21 | 11,610 | $11.76 | $136.5K | 80,074 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 1,774 | — | $0 | 14,190 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 7,292 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 2,431 | — | $0 | 14,583 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 7,292 | — | $0 | 14,583 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-05-17 | 2024-05-21 | 18,789 | — | $0 | 91,684 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-20 | 2024-02-21 | 12,053 | $14.11 | $170.1K | 72,895 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 2,430 | — | $0 | 17,014 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 7,292 | — | $0 | 7,292 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 7,292 | — | $0 | 29,167 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 1,774 | — | $0 | 15,964 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-02-17 | 2024-02-21 | 18,788 | — | $0 | 84,948 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-14 | 2024-02-16 | 39,886 | $15.01 | $598.7K | 66,160 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-02-11 | 2024-02-13 | 29,167 | — | $0 | 29,167 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2024-02-11 | 2024-02-13 | 60,000 | — | $0 | 106,046 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-11-20 | 2023-11-21 | 7,113 | $8.23 | $58.5K | 46,046 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 7,292 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 1,774 | — | $0 | 17,738 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 2,431 | — | $0 | 19,444 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-11-17 | 2023-11-21 | 11,497 | — | $0 | 53,159 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-08-18 | 2023-08-21 | 7,142 | $10.73 | $76.6K | 41,662 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 7,291 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 1,773 | — | $0 | 19,512 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 2,430 | — | $0 | 21,875 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-08-17 | 2023-08-21 | 11,494 | — | $0 | 48,804 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-05-18 | 2023-05-19 | 2,604 | $10.14 | $26.4K | 37,310 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-05-17 | 2023-05-19 | 2,431 | — | $0 | 24,305 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-05-17 | 2023-05-19 | 1,774 | — | $0 | 21,285 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-05-17 | 2023-05-19 | 4,205 | — | $0 | 39,914 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-05-22 | 2,430 | — | $0 | 26,736 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-02-23 | 2,430 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-02-23 | 1,774 | — | $0 | 23,059 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-02-17 | 2023-02-23 | 4,204 | — | $0 | 38,436 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-02-17 | 2023-02-23 | 2,727 | $7.66 | $20.9K | 35,709 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2023-01-11 | 2023-05-19 | 29,166 | — | $0 | 29,166 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-11-18 | 2022-11-21 | 1,139 | $5.44 | $6.2K | 34,232 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-11-17 | 2022-11-21 | 1,774 | — | $0 | 24,833 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-11-17 | 2022-11-21 | 1,774 | — | $0 | 35,371 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-08-17 | 2022-08-19 | 1,773 | — | $0 | 26,607 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-08-17 | 2022-08-19 | 1,773 | — | $0 | 34,742 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-08-17 | 2022-08-19 | 1,145 | $14.96 | $17.1K | 33,597 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 28,380 | — | $0 | 28,380 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 18,920 | — | $0 | 18,920 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-11-01 | 2021-11-03 | 5,000 | $18.07 | $90.3K | 32,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-08-02 | 2021-08-04 | 5,000 | $20.52 | $102.6K | 37,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-05-26 | 2021-05-28 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-06 | 5,000 | $24.84 | $124.2K | 42,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 10,389 | $33.74 | $350.5K | 51,780 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 3,311 | $32.94 | $109.1K | 48,469 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 500 | $31.87 | $15.9K | 47,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 800 | $35.39 | $28.3K | 62,169 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 31,000 | — | $0 | 31,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2020-12-16 | 2020-12-18 | 80,000 | — | $0 | 80,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-29 | 2020-11-02 | 5,000 | $17.48 | $87.4K | 62,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-21 | 2020-10-22 | 2,544 | $19.02 | $48.4K | 67,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-21 | 2020-10-22 | 3,500 | $17.68 | $61.9K | 70,513 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-20 | 2020-10-22 | 5,640 | $17.27 | $97.4K | 76,315 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-20 | 2020-10-22 | 2,302 | $18.01 | $41.5K | 74,013 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-16 | 2020-10-20 | 914 | $17.00 | $15.5K | 81,955 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-02-05 | 2020-02-07 | 100 | $17.10 | $1.7K | 82,869 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-12-20 | 2019-12-26 | 2,646 | — | $0 | 87,390 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-12-20 | 2019-12-26 | 2,646 | $17.02 | $45.0K | 82,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-12-20 | 2019-12-26 | 2,646 | — | $0 | 85,615 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-12-16 | 2019-12-16 | 3,010 | — | $0 | 90,036 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-12-16 | 2019-12-16 | 3,010 | — | $0 | 85,979 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-12-16 | 2019-12-16 | 3,010 | $17.05 | $51.3K | 82,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-12-13 | 2019-12-16 | 1,500 | — | $0 | 93,046 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-12-13 | 2019-12-16 | 1,500 | $17.05 | $25.6K | 82,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-12-13 | 2019-12-16 | 1,500 | — | $0 | 84,469 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-12-12 | 2019-12-16 | 199 | — | $0 | 94,546 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-12-12 | 2019-12-16 | 199 | $17.00 | $3.4K | 82,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-12-12 | 2019-12-16 | 199 | — | $0 | 83,168 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-07-22 | 2019-07-24 | 7,355 | — | $0 | 94,745 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-07-22 | 2019-07-24 | 7,355 | — | $0 | 90,324 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-07-22 | 2019-07-24 | 7,355 | $18.35 | $135.0K | 82,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2019-05-15 | 2019-05-17 | 27,900 | — | $0 | 27,900 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-04-22 | 2019-04-23 | 7,355 | — | $0 | 102,100 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-04-22 | 2019-04-23 | 7,355 | — | $0 | 90,324 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-04-22 | 2019-04-23 | 6,355 | $25.92 | $164.7K | 83,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-04-22 | 2019-04-23 | 1,000 | $26.79 | $26.8K | 82,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-01-25 | 2019-01-29 | 5,453 | — | $0 | 109,455 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-01-25 | 2019-01-29 | 5,453 | — | $0 | 88,422 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-01-25 | 2019-01-29 | 5,453 | $17.06 | $93.0K | 82,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-01-23 | 2019-01-24 | 600 | — | $0 | 114,908 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-01-23 | 2019-01-24 | 600 | $17.01 | $10.2K | 82,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-01-23 | 2019-01-24 | 600 | — | $0 | 83,569 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-01-22 | 2019-01-24 | 1,302 | — | $0 | 115,508 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-01-22 | 2019-01-24 | 1,302 | $17.00 | $22.1K | 82,969 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-01-22 | 2019-01-24 | 1,302 | — | $0 | 84,271 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-09-18 | 2018-09-20 | 52,600 | — | $0 | 52,600 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-06-04 | 2018-06-06 | 53,500 | — | $0 | 53,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2017-05-25 | 2017-05-26 | 33,800 | — | $0 | 33,800 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2016-11-21 | 2019-01-24 | 116,810 | — | $0 | 116,810 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2016-11-21 | 2016-11-29 | 116,810 | — | $0 | 116,810 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2016-11-21 | 2016-11-29 | 82,969 | — | $0 | 82,969 | SEC↗ |